Condition

Diabetic Foot Infection

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 18 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials18

Recruiting5

Common interventions25

Lead sponsors shown15

Clinical trials

18 shown

Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal UlcersNCT07747896 · 2026-08-01

RECRUITING

Study of Infrared Thermography in Diabetic Foot in GuadeloupeNCT07040488 · 2024-09-27

RECRUITING

Diabetic Foot Ulcer (DFU) Biofilm Infection and RecurrenceNCT05172089 · 2024-04-02

RECRUITING

PHOTOFINISH: a Clinical Study To Evaluate The Efficacy And Safety Of the System VULNOFAST® Plus/VULNOLIGHT® In Addition To The Usual Care (UC) Vs UC Alone For The Treatment Of Infected Diabetic Foot UlcersNCT05613985 · 2021-09-14

RECRUITING

Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot UlcersNCT05610865 · 2020-11-20

RECRUITING

Intraosseous Versus Intravenous Vancomycin in Below-Knee Amputation for Ischemic Diabetic FootNCT07338773 · 2025-08-06

COMPLETED

Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot UlcerNCT06667752 · 2024-10-17

ACTIVE_NOT_RECRUITING

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)NCT06526884 · 2024-07-22

COMPLETED

Diabetes Footcare Companion App for Patients and CarersNCT05564728 · 2023-06-23

COMPLETED

EPC Silver Wound Gel (EPC-123) Feasibility Study in the Management of Mildly Infected Diabetic Foot UlcersNCT05243810 · 2022-11-28

COMPLETED

Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI PatientsNCT05174806 · 2022-06-13

COMPLETED

Implementation of Telemedicine for Patient With Lower Extremity WoundsNCT04440839 · 2020-03-01

COMPLETED

A Pilot Study to Assess the Efficacy of NEOX® CORD 1K® in the Treatment of Complex Diabetic WoundsNCT03296436 · 2020-01-01

WITHDRAWN

Optimal Antibiotics for Operated Diabetic Foot InfectionsNCT04081792 · 2019-09-04

COMPLETED

Assessing the Efficacy of Anti-staphylococcal Phages in the Management of Infected Foot Ulcers in DiabetesNCT04289948 · 2019-03-01

WITHDRAWN

Studying on the Difference Between Two Kinds of OsteomyelitisNCT04240964 · 2017-07-01

COMPLETED

A Clinical Trial Testing the Efficacy of PDT in Preventing Amputation in Diabetic PatientsNCT03380403 · 2010-01-01

COMPLETED

Treatment of Chronic Diabetic Foot Ulcers by Minimally Invasive SurgeryNCT03010215 · 2010-01-01

UNKNOWN

Common interventions

Leading sponsors

Balgrist University Hospital 1 Başakşehir Çam & Sakura City Hospital 1 Centre Hospitalier Universitaire de la Guadeloupe 1 Exciton Technologies Inc. 1 Faculdade de Medicina do ABC 1 Johns Hopkins University 1 L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A. 1 Microbion Corporation 1 Nanfang Hospital, Southern Medical University 1 Nanordica Medical OU 1 Nanyang Technological University 1 Nordsjaellands Hospital 1 University Hospitals of Derby and Burton NHS Foundation Trust 1 University of California, Davis 1 University of California, Los Angeles 1

Trial status mix

COMPLETED9

RECRUITING5

WITHDRAWN2

ACTIVE_NOT_RECRUITING1

UNKNOWN1

Phase mix

NA9

PHASE12

PHASE22

EARLY_PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.